HHH EBITDA
$775.94MTTM · USD
Period ending:
HHH FY EBITDAUSD
$710.44M-$671.15M
2009-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
HHH ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 17 observations from Dec 31, 2009 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 517,788,000 | |
| 710,443,000 | |
| -389,353,000 | |
| 602,226,000 | |
| 399,265,000 | |
| 358,204,000 | |
| 364,712,000 | |
| 235,056,000 | |
| 316,315,000 | |
| 480,507,000 | |
| 309,923,000 | |
| 94,733,000 | |
| -20,308,000 | |
| -95,167,000 | |
| 54,123,000 | |
| -494,935,000 | |
| -671,145,000 |
Compare ebitda
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) ebitda
- HSBC Holdings, plc. Common Stock (HSBC) ebitda
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) ebitda
- Novartis AG Common Stock (NVS) ebitda
- Royal Bank Of Canada Common Stock (RY) ebitda
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) ebitda
- SAP SE ADS (SAP) ebitda
- AstraZeneca PLC Ordinary Shares (AZN) ebitda
All HHH financial metrics · HHH stock overview · How to interpret financial metrics